Nautilus Biotechnology (NAUT) News Today $0.73 -0.05 (-6.62%) Closing price 05/23/2025 04:00 PM EasternExtended Trading$0.74 +0.01 (+1.08%) As of 05/23/2025 06:39 PM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more. Add Compare Share Share Headlines Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestTrendsBuy This Stock NAUT Latest News All Sources Trusted Sources MarketBeat Benzinga Bloomberg GlobeNewswire GuruFocus MarketWatch Motley Fool NASDAQ PR Newswire Reuters Seeking Alpha TalkMarkets The Street TipRanks The Wall Street Journal Wall Street Zen Yahoo Finance Source Sentiment refers to the positivity or negativity of each headline according to our language processing algorithm. Sentiment All Sentiments Very Positive Positive Neutral Negative Very Negative Most Recent May 2025 April 2025 March 2025 February 2025 January 2025 December 2024 November 2024 October 2024 September 2024 August 2024 July 2024 June 2024 May 2024 April 2024 March 2024 February 2024 January 2024 December 2023 November 2023 October 2023 September 2023 August 2023 July 2023 June 2023 May 2023 April 2023 March 2023 February 2023 January 2023 December 2022 November 2022 October 2022 September 2022 August 2022 July 2022 June 2022 Time Period Nautilus Biotechnology And 2 Other Penny Stocks With Promising PotentialMay 15, 2025 | uk.finance.yahoo.comNautilus Biotechnology (NASDAQ:NAUT) Releases Quarterly Earnings Results, Beats Expectations By $0.01 EPSNautilus Biotechnology (NASDAQ:NAUT - Get Free Report) released its quarterly earnings results on Tuesday. The company reported ($0.13) EPS for the quarter, beating the consensus estimate of ($0.14) by $0.01.May 1, 2025 | marketbeat.comEarnings call transcript: Nautilus Biotechnology Q1 2025 surprises with EPS beatMay 1, 2025 | uk.investing.comNautilus Biotechnology Inc (NAUT) Q1 2025 Earnings Call Highlights: Strategic Cost Reductions ...April 30, 2025 | finance.yahoo.comNautilus Biotechnology, Inc. (NASDAQ:NAUT) Q1 2025 Earnings Call TranscriptApril 30, 2025 | msn.comQ1 2025 Nautilus Biotechnology Inc Earnings CallApril 30, 2025 | uk.finance.yahoo.comNautilus Biotechnology targets late 2026 platform launch amid proteoform assay advancementsApril 29, 2025 | msn.comNautilus Biotechnology, Inc. (NAUT) Q1 2025 Earnings Call TranscriptApril 29, 2025 | seekingalpha.comNautilus Biotechnology (NAUT) Projected to Post Earnings on TuesdayNautilus Biotechnology (NASDAQ:NAUT) will be releasing its Q1 2025 earnings before the market opens on Tuesday, April 29. (View Earnings Report at https://www.marketbeat.com/earnings/reports/2025-4-29-nautilus-biotechnology-inc-stock/)April 24, 2025 | marketbeat.comShort Interest in Nautilus Biotechnology, Inc. (NASDAQ:NAUT) Expands By 20.5%Nautilus Biotechnology, Inc. (NASDAQ:NAUT - Get Free Report) saw a large increase in short interest during the month of March. As of March 31st, there was short interest totalling 424,500 shares, an increase of 20.5% from the March 15th total of 352,300 shares. Currently, 0.7% of the company's shares are short sold. Based on an average daily volume of 137,600 shares, the short-interest ratio is presently 3.1 days.April 23, 2025 | marketbeat.comNautilus Biotechnology to Announce First Quarter 2025 Financial Results on April 29, 2025April 18, 2025 | seekingalpha.comNautilus Biotechnology, Inc. (NASDAQ:NAUT) Short Interest Up 20.8% in MarchNautilus Biotechnology, Inc. (NASDAQ:NAUT - Get Free Report) saw a significant increase in short interest during the month of March. As of March 15th, there was short interest totalling 352,300 shares, an increase of 20.8% from the February 28th total of 291,600 shares. Approximately 0.6% of the company's shares are short sold. Based on an average trading volume of 141,900 shares, the days-to-cover ratio is currently 2.5 days.April 4, 2025 | marketbeat.comWe're Keeping An Eye On Nautilus Biotechnology's (NASDAQ:NAUT) Cash Burn RateApril 1, 2025 | finance.yahoo.comNautilus Biotechnology, Inc. (NASDAQ:NAUT) CEO Sujal M. Patel Buys 53,300 SharesNautilus Biotechnology, Inc. (NASDAQ:NAUT - Get Free Report) CEO Sujal M. Patel acquired 53,300 shares of the company's stock in a transaction dated Wednesday, March 19th. The shares were bought at an average cost of $0.99 per share, for a total transaction of $52,767.00. Following the completion of the acquisition, the chief executive officer now directly owns 10,117,788 shares of the company's stock, valued at approximately $10,016,610.12. The trade was a 0.53 % increase in their ownership of the stock. The acquisition was disclosed in a legal filing with the Securities & Exchange Commission, which can be accessed through this hyperlink.March 22, 2025 | marketbeat.comInsider Buying: Nautilus Biotechnology, Inc. (NASDAQ:NAUT) CEO Purchases 53,300 Shares of StockMarch 22, 2025 | insidertrades.comNautilus Biotechnology price target lowered to $2.50 from $4 at GuggenheimFebruary 28, 2025 | markets.businessinsider.comNautilus Biotechnology, Inc. (NAUT) Q4 2024 Earnings Call TranscriptFebruary 28, 2025 | seekingalpha.comNautilus Biotechnology Inc (NAUT) Q4 2024 Earnings Call Highlights: Progress in Proteome ...February 28, 2025 | finance.yahoo.comNautilus Biotechnology lays off 16% of workforce, plans release of commercial platform in 2026February 27, 2025 | msn.comNautilus Biotechnology reports Q4 EPS (14c), consensus (18c)February 27, 2025 | markets.businessinsider.comNautilus CEO needs investor patience in pursuit of ‘incredibly ambitious’ biotech productFebruary 27, 2025 | msn.comNautilus Biotechnology (NAUT) Projected to Post Quarterly Earnings on ThursdayNautilus Biotechnology (NASDAQ:NAUT) will be releasing earnings before the market opens on Thursday, February 27. (Register for Conference Call at http://mmm.wallstreethorizon.com/u.asp?u=413070)February 20, 2025 | marketbeat.comNautilus Biotechnology to Participate in the TD Cowen 45th Annual Healthcare ConferenceFebruary 18, 2025 | markets.businessinsider.comNautilus Biotechnology, Inc. (NASDAQ:NAUT) Sees Significant Drop in Short InterestNautilus Biotechnology, Inc. (NASDAQ:NAUT - Get Free Report) was the target of a significant drop in short interest in January. As of January 31st, there was short interest totalling 272,000 shares, a drop of 68.8% from the January 15th total of 872,900 shares. Approximately 0.5% of the company's stock are sold short. Based on an average trading volume of 142,600 shares, the days-to-cover ratio is currently 1.9 days.February 12, 2025 | marketbeat.comNautilus Biotechnology (NASDAQ:NAUT) Trading Down 5.9% - Here's WhyNautilus Biotechnology (NASDAQ:NAUT) Stock Price Down 5.9% - Should You Sell?February 12, 2025 | marketbeat.comNAUT stock plunges to 52-week low, touches $1.6 amid market shiftsFebruary 11, 2025 | msn.comNautilus Biotech announces board member changesFebruary 1, 2025 | msn.comNautilus Biotechnology, Inc. (NASDAQ:NAUT) Short Interest Down 14.2% in DecemberNautilus Biotechnology, Inc. (NASDAQ:NAUT - Get Free Report) saw a large decline in short interest during the month of December. As of December 31st, there was short interest totalling 1,030,000 shares, a decline of 14.2% from the December 15th total of 1,200,000 shares. Currently, 1.8% of the shares of the stock are short sold. Based on an average daily trading volume, of 131,000 shares, the days-to-cover ratio is presently 7.9 days.January 16, 2025 | marketbeat.comJapan’s Kaneka buys Israeli medical device startup in $100 millon dealJanuary 9, 2025 | msn.comWith 32% ownership, Nautilus Biotechnology, Inc. (NASDAQ:NAUT) insiders have a lot riding on the company's futureDecember 9, 2024 | uk.finance.yahoo.comGoldman Sachs Downgrades Nautilus Biotechnology (NAUT)December 6, 2024 | msn.comNautilus Biotechnology (NASDAQ:NAUT) Stock Price Up 0.8% - Here's What HappenedNautilus Biotechnology (NASDAQ:NAUT) Trading 0.8% Higher - Should You Buy?November 23, 2024 | marketbeat.comNautilus Biotechnology, Inc. (NASDAQ:NAUT) Q3 2024 Earnings Call TranscriptOctober 31, 2024 | msn.comNautilus Biotechnology Faces ESG Challenges Amid Regulatory Pressure and Investor ScrutinyOctober 31, 2024 | markets.businessinsider.comNautilus Biotechnology Co-founder and Chief Scientist Parag Mallick, Ph.D., Honored with the Academy for Radiology and Biomedical Imaging Research's Distinguished Investigator AwardOctober 31, 2024 | globenewswire.comNautilus Biotechnology Inc (NAUT) Q3 2024 Earnings Call Highlights: Strategic Advances and ...October 30, 2024 | finance.yahoo.comNautilus Biotechnology Reports Q3 2024 Financial ResultsOctober 30, 2024 | msn.comNautilus Biotechnology to Participate in the Inaugural Guggenheim Healthcare ConferenceOctober 30, 2024 | globenewswire.comNautilus Biotechnology Reports Third Quarter 2024 Financial ResultsOctober 30, 2024 | markets.businessinsider.comQ3 2024 Nautilus Biotechnology Inc Earnings CallOctober 30, 2024 | finance.yahoo.comTD Cowen Keeps Their Buy Rating on Nautilus Biotechnolgy (NAUT)October 30, 2024 | markets.businessinsider.comNautilus Biotechnology (NAUT) Scheduled to Post Quarterly Earnings on TuesdayNautilus Biotechnology (NASDAQ:NAUT) will be releasing earnings before the market opens on Tuesday, October 29, Zacks reports. (Register for Conference Call at http://mmm.wallstreethorizon.com/u.asp?u=633846)October 22, 2024 | marketbeat.comWe Think Nautilus Biotechnology (NASDAQ:NAUT) Can Afford To Drive Business GrowthOctober 9, 2024 | finance.yahoo.comTech Moves: GE healthcare exec joins startup; Nautilus Biotech’s new CMO; WRF investor steps downSeptember 27, 2024 | msn.comNautilus Biotechnology, Inc. (NASDAQ:NAUT) VP Sells $134,978.97 in StockSeptember 26, 2024 | insidertrades.comNautilus Biotechnology, Inc. (NASDAQ:NAUT) VP Mary E. Godwin Sells 35,000 SharesSeptember 19, 2024 | insidertrades.comNautilus Biotechnology Insider Ups Holding During YearAugust 18, 2024 | finance.yahoo.comNautilus Biotechnology to Participate in the Morgan Stanley 22nd Annual Global Healthcare ConferenceAugust 14, 2024 | markets.businessinsider.comINOVIO Reports Q2 2024 Financial Results and Provides Business UpdateAugust 13, 2024 | msn.comNautilus Biotechnology (NASDAQ:NAUT) Announces Quarterly Earnings ResultsNautilus Biotechnology (NASDAQ:NAUT - Get Free Report) announced its quarterly earnings data on Tuesday. The company reported ($0.14) earnings per share (EPS) for the quarter, topping the consensus estimate of ($0.16) by $0.02. During the same quarter last year, the firm posted ($0.13) earnings per share.July 31, 2024 | marketbeat.com Get Nautilus Biotechnology News Delivered to You Automatically Sign up to receive the latest news and ratings for NAUT and its competitors with MarketBeat's FREE daily newsletter. Email Address NAUT Media Mentions By Week NAUT Media Sentiment Learn about the media sentiment score. Each headline receives a score ranging from 2 (good news) to -2 (bad news). Our company news sentiment scores track the average news sentiment of articles about each company over the most recent 7 days in order to identify companies that are receiving positive press. NAUT News Sentiment▼0.000.75▲Average Medical News Sentiment NAUT News Coverage Learn about the media coverage comparison. We track news headlines from hundreds of news outlets and tag them by company. This chart compares the number of articles about this company in the last seven days compared with the average number of articles about this company on a typical week. NAUT Articles This Week▼01▲NAUT Articles Average Week Get Nautilus Biotechnology News Delivered to You Automatically Sign up to receive the latest news and ratings for NAUT and its competitors with MarketBeat's FREE daily newsletter. Email Address Related Companies and Tools Related Companies QSI News Today AEHR News Today QTRX News Today MASS News Today FEIM News Today RPID News Today SEER News Today KEQU News Today OWLT News Today INTT News Today Headlines Tools Trending Media MentionsHigh Media Sentiment StocksLive News FeedMarketBeat OriginalsStock Ideas This page (NASDAQ:NAUT) was last updated on 5/25/2025 by MarketBeat.com Staff From Our PartnersGold Hits New Highs as Global Markets SpiralWhen Trump took office in 2017, gold was just $1,100 an ounce. By the time he left, it had soared to $1,839. ...Premier Gold Co | SponsoredWhite House to reset Social Security?Elon Musk's parting DOGE gift looks set to shock America... A single announcement by July 22nd could soon b...Altimetry | SponsoredBuffett’s favorite chart just hit 209% – here’s what that means for goldA Historic Gold Announcement Is About to Rock Wall Street For months, sharp-eyed analysts have watched the ...Golden Portfolio | SponsoredA grave, grave error.I thought what happened 25 years ago was a once- in-a-lifetime event… but how wrong I was. Because here we...Porter & Company | SponsoredIs President Trump Lying To You With This?President Trump’s economic transition isn’t without hardship. But what if there were a smart, tax-free way to ...Colonial Metals | SponsoredTrump’s Bitcoin Reserve is No Accident…Bitcoin's supply is being drained at unprecedented rates, but while most investors focus solely on Bitcoin, th...Crypto 101 Media | SponsoredTrump Exec Order 14179 is wealth “gift” to good Americans?Is President Trump’s Executive Order 14179… A secret way to restore wealth for good citizens? If you’ve ...Paradigm Press | SponsoredThis Signal Only Flashes Once Every 4 Years – And It Just TriggeredThis same signal has appeared twice before in the past 8 years — both times, it kicked off major moves in cryp...Crypto Swap Profits | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Nautilus Biotechnology, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share Nautilus Biotechnology With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Buy NAUT Stock Free NAUT Stock Alerts